Related Experiment Video
Updated: Jul 2, 2026

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes
Published on: January 16, 2015
MYC stimulates EZH2 expression by repression of its negative regulator miR-26a
Sandrine Sander1, Lars Bullinger, Kay Klapproth
1Institute of Physiological Chemistry, University of Ulm, Ulm, Germany.
Abstract:
The MYC oncogene, which is commonly mutated/amplified in tumors, represents an important regulator of cell growth because of its ability to induce both proliferation and apoptosis. Recent evidence links MYC to altered miRNA expression, thereby suggesting that MYC-regulated miRNAs might contribute to tumorigenesis. To further analyze the impact of MYC-regulated miRNAs, we investigated a murine lymphoma model harboring the MYC transgene in a Tet-off system to control its expression. Microarray-based miRNA expression profiling revealed both known and novel MYC targets. Among the miRNAs repressed by MYC, we identified the potential tumor suppressor miR-26a, which possessed the ability to attenuate proliferation in MYC-dependent cells. Interestingly, miR-26a was also found to be deregulated in primary human Burkitt lymphoma samples, thereby probably being of clinical relevance. Although today only few miRNA targets have been identified in human disease, we could show that ectopic expression of miR-26a influenced cell cycle progression by targeting the bona fide oncogene EZH2, a Polycomb protein and global regulator of gene expression yet unknown to be regulated by miRNAs. Thus, in addition to directly targeting protein-coding genes, MYC modulates genes important to oncogenesis via deregulation of miRNAs, thereby vitally contributing to MYC-induced lymphomagenesis.
Insights
The MYC oncogene regulates cell growth and microRNA (miRNA) expression. MYC-repressed miR-26a suppresses lymphoma cell proliferation by targeting EZH2, highlighting miRNA
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- The MYC oncogene is a key regulator of cell proliferation and apoptosis, frequently altered in tumors.
- Emerging evidence suggests MYC influences tumorigenesis through microRNA (miRNA) expression.
- Understanding MYC-regulated miRNAs is crucial for deciphering cancer development.
Purpose of the Study:
- To investigate the role of MYC-regulated miRNAs in lymphomagenesis.
- To identify specific miRNAs targeted by MYC and their functional impact.
- To explore the therapeutic potential of targeting MYC-miRNA interactions.
Main Methods:
- Utilized a murine lymphoma model with a Tet-off system to control MYC expression.
- Performed microarray-based miRNA expression profiling to identify MYC targets.
- Investigated the function of miR-26a in MYC-dependent cells and its target genes.
Main Results:
- Identified novel and known MYC-regulated miRNAs, including tumor suppressor miR-26a, which is repressed by MYC.
- Demonstrated that miR-26a attenuates proliferation in MYC-dependent lymphoma cells.
- Showed that miR-26a targets the oncogene EZH2, impacting cell cycle progression, and is deregulated in human Burkitt lymphoma.
Conclusions:
- MYC contributes to lymphomagenesis not only by directly regulating protein-coding genes but also by altering miRNA expression.
- miR-26a acts as a tumor suppressor by targeting EZH2 and regulating cell cycle.
- MYC-deregulated miRNAs, like miR-26a, represent potential therapeutic targets in MYC-driven cancers.
Related Concept Videos
Master Transcription Regulators
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic cells are...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
MicroRNAs
MicroRNAs

